Onconova Therapeutics Inc. (ONTX) is priced at $0.55 after the most recent trading session. At the very opening of the session, the stock price was $0.58 and reached a high price of $0.5988, prior to closing the session it reached the value of $0.59. The stock touched a low price of $0.5311.
Recently in News on May 10, 2021, Onconova Therapeutics to Provide Corporate Update and Announce First Quarter 2021 Financial Results on May 17, 2021. Company to host conference call and webcast at 4:30 p.m. Eastern Time on Monday, May 17. You can read further details here
Onconova Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.9300 on 02/18/21, with the lowest value was $0.4350 for the same time period, recorded on 01/04/21.
Onconova Therapeutics Inc. (ONTX) full year performance was 65.30%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Onconova Therapeutics Inc. shares are logging -71.76% during the 52-week period from high price, and 186.69% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.19 and $1.93.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 7564012 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Onconova Therapeutics Inc. (ONTX) recorded performance in the market was 17.00%, having the revenues showcasing -46.57% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 128.51M, as it employees total of 11 workers.
The Analysts eye on Onconova Therapeutics Inc. (ONTX)
During the last month, 0 analysts gave the Onconova Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.8574, with a change in the price was noted +0.2160. In a similar fashion, Onconova Therapeutics Inc. posted a movement of +65.65% for the period of last 100 days, recording 39,623,500 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ONTX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Onconova Therapeutics Inc. (ONTX)
Raw Stochastic average of Onconova Therapeutics Inc. in the period of last 50 days is set at 1.70%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 4.99%. In the last 20 days, the company’s Stochastic %K was 5.96% and its Stochastic %D was recorded 8.57%.
Considering, the past performance of Onconova Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 17.00%. Additionally, trading for the stock in the period of the last six months notably improved by 108.81%, alongside a boost of 65.30% for the period of the last 12 months. The shares increased approximately by -17.80% in the 7-day charts and went up by -33.67% in the period of the last 30 days. Common stock shares were lifted by -46.57% during last recorded quarter.